Skip to main content
. 2016 Oct 1;16(4):327–338. doi: 10.1007/s40268-016-0144-x

Fig. 5.

Fig. 5

Existing incidence of measles and average cost per case averted for immunization. Note: costs are computed under the scenario of 95 % vaccine coverage and 85 % vaccine effectiveness. MN microneedle, SC Inj. subcutaneous injection